Drug intelligence / Profile preview

intralipid + heparin

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

Intralipid + heparin is a combination of two intravenous agents used together primarily in research and specialized clinical settings. Intralipid is an intravenous fat emulsion composed mainly of soybean oil, egg phospholipids, and glycerin, used to provide calories and essential fatty acids to patients requiring parenteral nutrition[8]. Heparin is an anticoagulant that prevents blood clot formation by enhancing the activity of antithrombin III, thereby inhibiting thrombin and factor Xa[1][4][5]. When administered together as an infusion (often referred to as "Intralipid/heparin infusion"), this combination can be used experimentally to elevate plasma free fatty acid levels for metabolic studies or in certain protocols where both lipid delivery and prevention of catheter clotting are required[6][3]. The mechanism involves Intralipid supplying lipids for energy/nutrition while heparin prevents coagulation during prolonged infusions.

Other names
intralipid + heparin
02

Targets

F10 (Factor Xa)ATIII (Antithrombin III)F2 (Thrombin)

Beyond the preview

Go deeper on intralipid + heparin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on intralipid + heparin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call